J030-1385 Screening compound: 8-chloro-2-[(4-methylpiperidino)sulfonyl]-3-phenoxydibenzo[b,f][1,4]oxazepin-11(10H)-one

J030-1385 Screening compound: 8-chloro-2-[(4-methylpiperidino)sulfonyl]-3-phenoxydibenzo[b,f][1,4]oxazepin-11(10H)-one
J030-1385 Screening compound: 8-chloro-2-[(4-methylpiperidino)sulfonyl]-3-phenoxydibenzo[b,f][1,4]oxazepin-11(10H)-one alternative view

Chemical Structure Depiction of ChemDiv screening compound J030-1385
8-chloro-2-[(4-methylpiperidino)sulfonyl]-3-phenoxydibenzo[b,f][1,4]oxazepin-11(10H)-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J030-1385

Molecular Formula

C25H23ClN2O5S (C25 H23 ClN2 O5 S)

Compound Name

8-chloro-2-[(4-methylpiperidino)sulfonyl]-3-phenoxydibenzo[b,f][1,4]oxazepin-11(10H)-one

IUPAC name

6-chloro-13-[(4-methylpiperidin-1-yl)sulfonyl]-14-phenoxy-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(15)3571113-hexaen-10-one

SMILES

CC(CC1)CCN1S(c(c(Oc1ccccc1)c1)cc2c1Oc(ccc(Cl)c1)c1NC2=O)(=O)=O

InChI

InChI=1S/C25H23ClN2O5S/c1-16-9-11-28(12-10-16)34(30,31)24-14-19-22(15-23(24)32-18-5-3-2-4-6-18)33-21-8-7-17(26)13-20(21)27-25(19)29/h2-8,13-16H,9-12H2,1H3,(H,27,29)

InChI Key

KNHGJCICHHWKMJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27220602

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.99

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.725

Distribution Coefficient, logD

5.023

Water Solubility, LogSw

-5.86

Polar Surface Area

70.885

Acid Dissociation Constant (pKa)

6.79

Base Dissociation Constant (pKb)

-4.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

J030-1385 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with J030-1385 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J030-1385?
Check Price and Availability of J030-1385, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J030-1385 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J030-1385
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J030-1385
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J030-1385 available by request